Am I eligible for this trial based on my specific type of glioma?

This is a question you may want to discuss with your doctor regarding the Pembrolizumab, Olaparib, and Temozolomide for People With Glioma clinical trial (NCT05188508). Contact the study team or your healthcare provider for specific answers.

What are the potential side effects of the treatments being tested?

This is a question you may want to discuss with your doctor regarding the Pembrolizumab, Olaparib, and Temozolomide for People With Glioma clinical trial (NCT05188508). Contact the study team or your healthcare provider for specific answers.

How does this treatment compare to my current options?

This is a question you may want to discuss with your doctor regarding the Pembrolizumab, Olaparib, and Temozolomide for People With Glioma clinical trial (NCT05188508). Contact the study team or your healthcare provider for specific answers.

What will the treatment schedule look like, and how often will I need to visit the clinic?

This is a question you may want to discuss with your doctor regarding the Pembrolizumab, Olaparib, and Temozolomide for People With Glioma clinical trial (NCT05188508). Contact the study team or your healthcare provider for specific answers.

What kind of monitoring will be done during the trial?

This is a question you may want to discuss with your doctor regarding the Pembrolizumab, Olaparib, and Temozolomide for People With Glioma clinical trial (NCT05188508). Contact the study team or your healthcare provider for specific answers.

Are there any costs associated with participating in this trial?

This is a question you may want to discuss with your doctor regarding the Pembrolizumab, Olaparib, and Temozolomide for People With Glioma clinical trial (NCT05188508). Contact the study team or your healthcare provider for specific answers.

Finding studies

Back

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

NCT0518850810 sitesClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Clareo Health | Pembrolizumab, Olaparib, and Temozolomide for People With Glioma